1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Colombia Pharmaceuticals and Healthcare Report Q2 2016

Colombia Pharmaceuticals and Healthcare Report Q2 2016

  • April 2016
  • -
  • Business Monitor International
  • -
  • 85 pages

Includes 3 FREE quarterly updates

Headline Expenditure Projections

- Pharmaceuticals: COP9,101bn (USD3.31bn) in 2015 to COP9,584bn (USD2.92bn) in 2016; +5.3% inlocal currency and -12.0% in US dollars.

- Healthcare: COP54,299bn (USD19.8bn) in 2015 to COP57,940bn (USD17.6bn) in 2016; +6.7% in localcurrency and -10.9% in US dollars.

Table Of Contents

Colombia Pharmaceuticals and Healthcare Report Q2 2016
BMI Industry View 7
Table: Headline Pharmaceuticals and Healthcare Forecasts (Colombia 2014-2020) 7
SWOT 9
Industry Forecast 11
Pharmaceutical Market Forecast 11
Table: Pharmaceutical Sales, Historical Data And Forecasts (Colombia 2012-2020) 13
Healthcare Market Forecast 14
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Colombia 2012-2020) 16
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Colombia 2012-2020) 17
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Colombia 2012-2020) 17
Prescription Drug Market Forecast 18
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Colombia 2012-2020) 19
Patented Drug Market Forecast 20
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Colombia 2012-2020) 21
Generic Drug Market Forecast 22
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Colombia 2012-2020) 24
OTC Medicine Market Forecast 25
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Colombia 2012-2020) 27
Pharmaceutical Trade Forecast 28
Table: Pharmaceutical Trade Data And Forecasts (Colombia 2014-2020) 30
Table: Pharmaceutical Trade Data And Forecasts local currency (Colombia 2014-2020) 30
Pharmaceuticals Risk/Reward Index 31
Americas Risk/Reward Index 31
Colombia Risk/Reward Index 37
Rewards 37
Risks 38
Market Overview 39
Healthcare Sector 40
Table: Healthcare Resources (Colombia 2010-2015) 44
Table: Healthcare Personnel (Colombia 2010-2015) 44
Table: Healthcare Activity (Colombia 2010-2015) 45
Research and Development 45
Table: Pharmaceutical Research and Science Centre (CECIF) Members, 2015 45
Clinical Trials 46
Epidemiology 47
Regulatory Review 50
Intellectual Property Regime 51
Table: Colombia-US FTA Mechanisms Relevant To Intellectual Property 54
Pricing Regime 54
Reimbursement Regime 56
Competitive Landscape 59
Research-Based Industry 59
Table: Members Of Asociación De Laboratorios Farmaceuticos De Investigación (AFIDRO), 2012 60
Table: Multinational Market Activity 61
Table: Leading Pharmaceutical Companies By Revenues, 2011 (COPmn) 62
Pharmaceutical Distribution 63
Table: Leading Pharmaceutical Importers/Wholesalers By Revenues, 2011 63
Pharmaceutical Retail Sector 65
Company Profile 66
Laboratorios Bussie 66
Laboratorios Genfar SA 68
Lafrancol 71
Demographic Forecast 74
Table: Population Headline Indicators (Colombia 1990-2025) 75
Table: Key Population Ratios (Colombia 1990-2025) 75
Table: Urban/Rural Population and Life Expectancy (Colombia 1990-2025) 76
Table: Population By Age Group (Colombia 1990-2025) 76
Table: Population By Age Group % (Colombia 1990-2025) 77
Glossary 79
Methodology 81
Pharmaceutical Expenditure Forecast Model 81
Healthcare Expenditure Forecast Model 81
Notes On Methodology 82
Risk/Reward Index Methodology 83
Index Overview 84
Table: Pharmaceutical Risk/Reward Index Indicators 84
Indicator Weightings 85

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

  • $ 10995
  • Industry report
  • September 2016
  • by Global Data

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024 Summary Attention deficit hyperactivity disorder (ADHD) is characterized by excessive levels ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

  • $ 6995
  • Industry report
  • November 2016
  • by GBI Research

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation Summary Asthma is a chronic condition affecting ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.